Whole genome sequencing in CLL: challenges and benefits
Where will leukemia research go next?
Preliminary results of the AIM trial of ibrutinib and venetoclax in mantle cell lymphoma
Matched unrelated donor (MUD) transplantations for ALL and AML
Panobinostat and donor lymphocyte infusions in patients with high-risk AML and MDS